CHG-2023-0118

Facility Change for Crizotinabex. Manufacturing Process Change for Crizotinabex — minor update. Impacts 6 markets and 4 variations.

Change Number
CHG-2023-0118
Type
Facility Change
Product
Crizotinabex
Status
Pending
Owner
Sarah Chen
Initiated
2022-09-14
Description

Manufacturing Process Change for Crizotinabex — minor update

Impacted Markets (6)
US — United StatesDE — GermanySG — SingaporeMX — MexicoSE — SwedenBE — Belgium
Impacted Modules
4.2.13.2.P2.3.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved